News Articles and Montana BioScience Alliance Newsletters


A vaccine for tuberculosis exists, but TB is still the 2nd leading infectious killer in the world after Covid-19, according to the World Health Organization. With a $12.3 million contract from the National Institutes of Health, researchers at the University of Montana are hoping to improve the vaccine for TB and positively influence global health.

Children with Autism Spectrum Disorder are at Risk for Low Bone Density. Preliminary Data Suggest that the Administration of Oxytocin May Favorably Impact Bone Formation and Strength

Rocky Mountain Labs
November 13, 2023

It’s entirely possible that the secret to understanding — perhaps even vanquishing — the coronavirus rests in this quiet town of 5,000 nestled at the edge of the wilderness.

Regional Innovation and Technology Hub
November 12, 2023

A consortium of Montana businesses, universities, and workforce development groups have been designated as one of 31 newly announced Regional Innovation and Technology Hubs that will be able to utilize portions of $75 million in grant money to advance American technology.

Montana BioScience Alliance
October 29, 2023

High school students in Billings, Montana recently had the unique opportunity to explore the various career paths available in the healthcare industry. The event, called the Montana BioScience Alliance Careers in Healthcare, aimed to inspire and educate students about the exciting opportunities that await them in the medical field.


National Institutes of Health
March 27, 2023

SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. The next deadline is April 5. Omnibus Solicitations. Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These FOAs do not specify a topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations. Specific Funding […]

FDA advisers endorsed the safety and efficacy of GSK’s respiratory syncytial virus (RSV) vaccine in older adults, setting up a final mad dash with Pfizer as both companies eye the regulatory finish line with their promising new vaccines.

Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology  that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.

Doctors have told health services to prepare for a new era of cancer screening after a study found a simple blood test could spot multiple cancer types in patients before they develop clear symptoms.

It’s been 60 years since President Kennedy delivered his iconic moonshot speech, marking a goal for America to launch a man into space to step foot on the moon, and bring him back to Earth. On Sept. 12, President Biden gave a speech at the Kennedy Presidential Library in Boston, outlining the progress on his own self-described moonshot: ending cancer.


October 18, 2023

View the Fall 2023 Newsletter now!

July 28, 2023

View the Summer 2023 Newsletter now!